参考文献/References:
[1]Divo M,Cote C,de Torres JP,et al.Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2012,186(2):155-161.[2]Graat-Verboom L,Wouters EF,Smeenk FW,et al.Current status of research on osteoporosis in COPD: a systematic review[J].Eur Respir J,2009,34(1):209-218.[3]Saeed A,Parveen H,Jamil B.Evaluation of risk factors causing osteoporosis in chronic obstructive pulmonary disease (COPD) Patients[J].Journal of Medicine,Physiology and Biophysics,2019,54:43-49.[4]Lin CH,Chen KH,Chen CM,et al.Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan[J].Peer J,2018,6:e4232.[5]Lin CW,Chen YY,Chen YJ,et al.Prevalence,risk factors,and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan[J].Int J Chron Obstruct Pulmon Dis,2015,10:1493-500.[6]Graat-Verboom L,Spruit MA,van den Borne BE,et al.Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component[J].Respir Med,2009,103(8):1143-1151.[7]Lee SH,Kwon HY.Prevalence of Osteoporosis in Korean Patients with Chronic Obstructive Pulmonary Disease and Their Health-related Quality of Life According to the Korea National Health and Nutrition Examination Survey 2008-2011[J].J Bone Metab,2017,24(4):241-248.[8]Liang B,Feng Y.The association of low bone mineral density with systemic inflammation in clinically stable COPD[J].Endocrine,2012,42(1):190-195.[9]Liu WT,Kuo HP,Liao TH,et al.Low bone mineral density in COPD patients with osteoporosis is related to low daily physical activity and high COPD assessment test scores[J].Int J Chron Obstruct Pulmon Dis,2015,10:1737-144.[10]Lu PC,Yang YH,Guo SE,et al.Factors associated with osteoporosis in patients with chronic obstructive pulmonary disease-a nationwide retrospective study[J].Osteoporos Int,2017,28(1):359-367.[11]刘伟新,苗亚飞,刘丁君.慢性阻塞性肺疾病患者合并骨质疏松的患病情况及危险因素[J].中国卫生工程学,2018,17(3):465-467.[12]李俏俏.不同分期的COPD患者并发骨质疏松的相关因素分析[J].医学研究杂志,2014,43(8):150-155.[13]王鹏飞,许建英,刘虎.慢性阻塞性肺疾病继发骨质疏松症患者血清高密度脂蛋白胆固醇水平的变化[J].中华结核和呼吸杂志,2012,35(4):293-294.[14]胡美.慢性阻塞性肺疾病患者发生骨质疏松的危险因素探讨[D].重庆:第三军医大学,2009.[15]蔡明文.慢性阻塞性肺疾病合并骨质疏松的危险因素分析[J].现代中西医结合杂志,2014,23(1):50-52.[16]赵晓辉.慢性阻塞性肺疾病患者合并骨质疏松症的中医证型分布及相关性分析[D].北京:北京中医药大学,2021.[17]Pompe E,Bartstra J,Verhaar HJ,et al.Bone density loss on computed tomography at 3-year follow-up in current compared to former male smokers[J].Eur J Radiol,2017,89:177-181.[18]Braun KF,Ehnert S,Freude T,et al.Quercetin protects primary human osteoblasts exposed to cigarette smoke through activation of the antioxidative enzymes HO-1 and SOD-1[J].Scientific World Journal,2011,11:2348-2357.[19]Ward KD,Klesges RC.A meta-analysis of the effects of cigarette smoking on bone mineral density[J].Calcif Tissue Int,2001,68(5):259-270.[20]De Laet C,Kanis JA,Odén A,et al.Body mass index as a predictor of fracture risk: a meta-analysis[J].Osteoporos Int,2005,16(11):1330-1338.[21]Remels AH,Gosker HR,Langen RC,et al.The mechanisms of cachexia underlying muscle dysfunction in COPD[J].J Appl Physiol (1985),2013,114(9):1253-1262.[22]Okazaki R,Watanabe R,Inoue D.Osteoporosis Associated with Chronic Obstructive Pulmonary Disease[J].J Bone Metab,2016,23(3):111-120.[23]Lange P,Celli B,Agustí A,et al.Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease[J].N Engl J Med,2015,373(2):111-122.[24]Takabatake N,Nakamura H,Abe S,et al.The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2000,161(4 Pt 1):1179-1184.[25]Koh JM,Khang YH,Jung CH,et al.Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis[J].Osteoporos Int,2005,16(10):1263-1271.[26]F?覬rli L,Halse J,Haug E,et al.Vitamin D deficiency,bone mineral density and weight in patients with advanced pulmonary disease[J].J Intern Med,2004,256(1):56-62.[27]Zhu B,Zhu B,Xiao C,et al.Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis[J].Int J Chron Obstruct Pulmon Dis,2015,10:1907-1916.[28]Brot C,Jorgensen NR,Sorensen OH.The influence of smoking on vitamin D status and calcium metabolism[J].Eur J Clin Nutr,1999,53(12):920-926.[29]van Staa TP,Leufkens HG,Abenhaim L,et al.Oral corticosteroids and fracture risk: relationship to daily and cumulative doses[J].Rheumatology (Oxford),2000,39(12):1383-1389.[30]Maggi S,Siviero P,Gonnelli S,et al.Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study[J].J Clin Densitom,2009,12(3):345-352.[31]Rao CM,Singh P,Maikap D,et al.Musculoskeletal Disorders in Chronic Obstructive Airway Diseases: A Neglected Clinical Entity[J].Mediterr J Rheumatol,2021,32(2):118-123.[32]Van Staa TP,Laan RF,Barton IP,et al.Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy[J].Arthritis Rheum,2003,48(11):3224-3229.[33]Watanabe R,Tanaka T,Aita K,et al.Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function[J].J Bone Miner Metab,2015,33(4):392-400.[34]Silva DR,Coelho AC,Dumke A,et al.Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study[J].Respir Care,2011,56(7):961-968.[35]黄宏兴,吴青,李跃华,等.肌肉、骨骼与骨质疏松专家共识[J].中国骨质疏松杂志,2016,22(10):1221-1229,1236.
相似文献/References:
[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(24):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(24):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(24):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(24):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及
炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(24):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病
引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(24):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并
重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Journal of Medical Information,2018,31(24):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]何冬兰,李 文.NLR、PLR在慢性阻塞性肺疾病进展、预后中的相关研究[J].医学信息,2022,35(11):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
HE Dong-lan,LI Wen.Study on Correlation Between NLR and PLR in the Progression and Prognosis of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(24):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
[10]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及
MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(24):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
[11]姜 瑞,张 征,谭爱华.慢性阻塞性肺疾病与骨质疏松症的生物信息学分析[J].医学信息,2023,36(17):1.[doi:10.3969/j.issn.1006-1959.2023.17.001]
JIANG Rui,ZHANG Zheng,TAN Ai-hua.Bioinformatics Analysis of Chronic Obstructive Pulmonary Disease and Osteoporosis[J].Journal of Medical Information,2023,36(24):1.[doi:10.3969/j.issn.1006-1959.2023.17.001]